Furthermore, sustained tumor regression was only achieved in combination with anti-PD-1 monoclonal antibodies, possibly due to anti-PD-1 antibodies reversing CAR T-cell exhaustion (102). The gene discussed is PDCD1; the disease is neoplasm.